Stifel has added Cooper Companies (COO+1.7%) to its Select List and boosted its price target to $450 from $405.
Analyst Jonathan D. Block highlights several catalysts for the company, incljuding a strong back-to-school season, strong outlook for CooperVision's MyDay multifocal lens, and potential approval for MiSight in China.
He adds that in the long term, MiSight could address pediatric pediatric myopic management, "a pandemic that is only expected to worsen in coming years."